|
Grouped-level disorder
|
Count
|
Overall prevalence %
|
95% CIa
|
Female prevalence %
|
Male prevalence %
|
P-Valueb
|
Median age (years)
|
|---|
|
Cutaneous
|
468
|
22.7
|
20.9–24.6
|
19.9
|
25.2
|
0.004
|
8.3
|
|
Dental
|
367
|
17.8
|
16.2–19.6
|
19.4
|
16.6
|
0.096
|
8.9
|
|
Aural
|
254
|
12.3
|
11.0–13.8
|
10.5
|
13.9
|
0.020
|
8.9
|
|
Claw/nail
|
179
|
8.7
|
7.5–10.0
|
9.3
|
8.2
|
0.365
|
8.4
|
|
Musculoskeletal
|
162
|
7.9
|
6.7–9.1
|
8.9
|
7.0
|
0.115
|
9.3
|
|
Enteropathic
|
146
|
7.1
|
6.0–8.3
|
8.2
|
6.2
|
0.087
|
8.0
|
|
Ophthalmological
|
143
|
6.9
|
5.9–8.1
|
7.5
|
6.5
|
0.356
|
10.8
|
|
Anal sac
|
127
|
6.2
|
5.2–7.3
|
6.9
|
5.6
|
0.221
|
7.3
|
|
Obesity
|
126
|
6.1
|
5.1–7.2
|
7.1
|
5.3
|
0.092
|
7.2
|
|
Mass-associated
|
109
|
5.3
|
4.4–6.4
|
5.9
|
4.7
|
0.205
|
11.7
|
|
Neoplastic
|
101
|
4.9
|
4.0–5.9
|
4.5
|
5.2
|
0.418
|
11.3
|
|
Parasite infestation
|
96
|
4.7
|
3.8–5.7
|
5.0
|
4.4
|
0.543
|
7.3
|
|
Behavioural
|
77
|
3.7
|
3.0–4.7
|
2.9
|
4.5
|
0.051
|
7.6
|
|
Lower respiratory tract
|
45
|
2.2
|
1.6–2.9
|
3.2
|
1.4
|
0.005
|
11.8
|
|
Cardiac
|
40
|
1.9
|
1.4–2.6
|
1.9
|
2.0
|
0.904
|
12.5
|
|
Upper respiratory tract
|
39
|
1.9
|
1.4–2.6
|
1.4
|
2.3
|
0.111
|
8.9
|
|
Endocrine
|
38
|
1.8
|
1.3–2.5
|
2.1
|
1.6
|
0.403
|
11.1
|
|
Urinary
|
38
|
1.8
|
1.3–2.5
|
2.9
|
1.0
|
0.002
|
12.7
|
|
Traumatic
|
33
|
1.6
|
1.1–2.2
|
1.2
|
2.0
|
0.143
|
5.3
|
- aCI confidence interval bP-Values in bold highlight disorders that differ in prevalence between males and females
